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Nowadays, hypertension is one of the most important causes of death all over the world because of its 
adverse effects on cardiovascular system. For this reason its study is very valuable. Vitamin D is one 
of the important factors that may influence blood pressure. Many studies have shown the 
modulatory effect of this vitamin on rennin-angiotensin system as well as its inhibitory effect on 
vascular smooth muscle hypertrophy. According to the fact that vitamin receptors are distributed in 
almost all organs of human body, we can't consider its role just as factor in calcium homeostasis. 
Therefore many other important roles could be attributed to it. So vitamin D deficiency could arise 
many problems. There are many causes for vitamin D deficiency. The most important is insufficient 
exposure to UV-B. In epidemiological studies the vitamin D deficiency is considered to be associated 
with high blood pressure, as emphasized in many cross-sectional studies. Concerning the cohort 
prospective studies, the relationship between vitamin D deficiency and hypertension is reported in 
some cases. The interventional studies about the association between vitamin D and hypertension are 
not many and the results are different or contradictory. Controversial results might be due to 
differences in dose of supplements or duration of supplement therapy. The aim of this systematic 
review is to assess the researches about the association between vitamin D deficiency and 
hypertension and discuss the power of them. This can be helpful to lighten the path to prospective 
investigations. 
Copyright © 2014 Zahedan University of Medical Sciences. All rights reserved. 
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          Introduction 
 
owadays, hypertension can be fatal. Hypertension 
has adverse effects on cardiovascular system. 
When systolic and diastolic blood pressures are 
equal or more than 140 and 90 mm Hg respectively, they 
are considered high. It has been specified that an increase 
of about 2 mm Hg systolic blood pressure can increase 
cardiovascular complications induced death rate [1, 2]. 
For this reason, studies about blood pressure and factors 
affecting it are one of the important topics in medical 
sciences. Vitamin D is one of the factors that can affect 
blood pressure. Nowadays, vitamin D has been 
considered, due to its various effects on health, and 
numerous studies have been conducted on its various 
effects on different parts of body and proper functioning 
of different organs and systems. It is also claimed that 
vitamin D deficiency leads to many chronic diseases. 
Thus, from 1980 onwards, vitamin D has become a 
particular interest of researchers, and it is no longer 
considered to be just a factor in regulating calcium 
homeostasis [3]. Due to the wide distribution of vitamin 
D receptors in most of body tissues, several roles have 
been attributed to them. In a number of the chronic 
diseases such as cancers, diseases related to the immune 
system, cardiovascular complications and diseases, 
especially Hypertension, vitamin D deficiency or 
dysfunction can be traced. Studies indicate that 
insufficient intake of vitamin D plays an important role in 
pathogenesis and progression of hypertension. Vitamin D 
and its deficiency was well known in early 20th century 
after discovering its clinical effects on bone and its role in 
the development of several diseases such as rickets in 
children and osteoporosis in adults. So that in the years 
1999 and 2000, the Institute of Medicine recommended 
that people younger than 50, from 51 to 70, and above 70 
years old need, 200 IU, 400 IU, and 600 IU of vitamin D 
daily respectively. Later it was found that these amounts 
are sufficient when a person gets adequate sun exposure 
daily. In other words if people were not suffering vitamin 
D deficiency, these amounts are sufficient, but if the 
person was suffering from vitamin D deficiency or could 
not get enough sunlight due to his/her residence or age 
conditions, he/she would probably need higher doses of 
vitamin D. Vitamin D is fat-soluble and accounted steroid 
hormone. There are two major forms of vitamin D: 
vitamin DR2R (ergocalciferol) 5T and vitamin DR3R 
(cholecalciferol). Exposure of skin to sunlight is the major 
source of vitamin D for human, which provides 
approximately 95% of daily requirement [4]. The 
remaining 5% is supplied by diet. Foods like fish-liver oil, 
oily fish, liver, and egg yolk contain vitamin D [5]. In the 
United States certain foods such as milk, fruit juice, and 
cereals are fortified with vitamin DR2R [6]. This vitamin is 
the product of yeast and plants exposure to sunlight [7].  
One and 25-dihydroxyvitamin D are the active form of 
vitamin D, but 25-hydroxyvitamin D is used as a serum 
marker for the diagnosis of vitamin D deficiency due to 
its higher plasma concentration and longer half-life [8]. 
Basically, vitamin D deficiency is defined as: serum 25-
hydroxyvitamin D level is less than 20 ng/ml (50 nmol/l). 
However, 21 to 29 ng/ml levels of 25-hydroxyvitamin D 
are considered to be insufficient [9]. Researches indicate 
that low levels of vitamin D are common and maybe 
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epidemic in children and adults around the world [10-12]. 
It is estimated that about 1 billion people worldwide are 
suffering from some degrees of vitamin D deficiency 
[13]. In Iran, according to researchers conducted by 
Endocrinology and Metabolism Research Center of 
Tehran University of Medical Sciences, 40 to 805T%5T of 
people are suffering from vitamin D deficiency [14]. The 
results from studies conducted in different regions within 
Iran are: in a study in Tehran on a population aged 20-69 
years old, the prevalence of vitamin D deficiency was 
79.6% [15]; also in another study the prevalence was 77% 
in healthy people and 70% in diabetics [16]; the 
prevalence was 50.8% in Isfahan [17]; and the prevalence 
of vitamin D deficiency was 85.2% in Zahedan [18]. 
Vitamin D deficiency can occur for a number of reasons, 
which are presented in table 1. Given that exposure of 
skin to sunlight is the most common way to get vitamin 
D, limited sunlight exposure and as a result the lack of 
receiving UVB are the major and the most common 
causes of vitamin D deficiency [7]. Other factors might be 
the latitude of residence, skin color and aging (Table 1). 
On the other hand, hypertension is more common in 
higher latitudes [19]. Also, people with darker skin are 
more prone to high blood pressure and incidence of 
hypertension increases with age [20]. These cases may 
support the hypothesis maintaining that there is a 
relationship between vitamin D and hypertension. 
 
Materials and Methods 
In this review study the results of epidemiological, 
cross-sectional, and cohort studies on the relationship 
between serum vitamin D level and blood pressure are 
investigated. Interventional studies were also performed 
in order to study the effect of vitamin D supplement on 
blood pressure. For this purpose, a literature search of 
PubMed, ISI, Web of Knowledge, and Google Scholar 
database was conducted using vitamin D and (high) blood 
pressure as keywords. The collected studies were 
examined, after being classified based on the type of the 
study. Finally, in accordance with review article 
framework, the obtained results were placed in the tables 
by study type.  
Observational Studies: Observational studies details 
(epidemiologic, cross-sectional, and cohort) on the 
relationship between vitamin D and blood pressure are 
listed in table 2.  
1. Epidemiologic Studies: In most of these studies it has 
been stated that the prevalence of vitamin D deficiency 
and also hypertension arise with increasing distance from 
the equator (i.e. higher latitudes) [21-23]. Studies 
conducted on people with dark skin indicated that the 
prevalence of vitamin D deficiency was higher among 
them than white people. They are also more prone to 
hypertension [24-25]. Also, black people who emigrated 
from North Africa to the countries in the higher latitudes 
had higher blood pressure than native people of Northern 
Africa and their serum 25-hydroxyvitamin D level was 
lower [26-27]. In addition some of these studies have 
pointed out the seasonal variation in blood pressure and 
its relationship with vitamin D synthesis level, meaning 
that vitamin D synthesis level is lower in cold season than 
in hot seasons and blood pressure is higher in cold 
seasons than in hot seasons [24-25]. 
2.Cross-Sectional Studies: A relationship between 
vitamin D and hypertension has been observed in cross-
sectional studies, indicating that UVB ray is needed for 
vitamin D synthesis. As sunlight weakens due to greater 
distance from the equator or in cold seasons, the serum 
25-hydroxyvitamin D level decreases and blood pressure 
elevates [28-29]. In some of these cross-sectional studies 
it was found that by increasing plasma 25-hydroxyvitamin 
D levels, blood pressure will decrease [30-32]. In these 
studies it was also determined that sunlight played an 
important role in vitamin D synthesis [33-34]. However, 
these findings do not prove the relationship between 
vitamin D deficiency and hypertension individually, but 
considering that they address this relationship between 
diet and disease, and not at the nutrient levels, these 
findings are quite important and can be helpful in 
proposing hypothesis on the relationship between vitamin 
D and hypertension [35].  
3.Cohort Studies: Despite a limited number of cohort 
studies on this topic, following results have been 
obtained: The largest study was performed by Forman et 
al., on the participants in Health Professionals Follow-Up 
Study and Nurse’s Health Study, indicated that people 
with serum 25-hydroxyvitamin D levels were less than 15 
ng/ml were more prone to develop hypertension 
compared with those with serum 25-hydroxyvitamin D 
levels more than 30 ng/ml. In this study, serum 25-
hydroxyvitamin D levels of 613 men from the Health 
Professionals Follow-Up Study and 1198 women from the 
Nurse’s Health Study were measured. The participants, 
then, were followed for 4 to 8 years. After 4 years, the 
relative risk of hypertension among two groups of men 
with vitamin D levels less than 15 ng/ml and serum 
vitamin D levels were greater than or equal to 15 ng/ml 
were determined. 
 
Table 1. The most important causes for vitamin D deficiency 
 
Variable Mechanism 
Aging Reduction in 7-dehydroxy cholesterol in skin particularly in people more than 70 years old 
Hepatic failure Decreased synthesis of 25-hydroxyvitamin D 
Chronic renal failure Decreased synthesis of 1-25-dihydroxyvitamin D 
Malabsorption  Reduced bioavailability of vitamin D 
Obesity Retention of vitamin D in fat cells 
Season/latitude/time of day  Reduced skin synthesis 
Skin pigment Decrease UVB absorption 
Sun protection Reduced skin synthesis 
Increased catabolism   Anticonvulsant, glucocorticoid, highly active antiretroviral treatment, and some immunosuppressants 
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Table 2. Observational studies of the association of vitamin D and hypertension 
 
Result Design Study/Year 
Far from the equatorial, vitamin D decreased and 
blood pressure increased  
Comparison between blood pressure and vitamin D level in 
equatorial residents and people in high latitude 
Epidemiologicv Haddock et 
al.[29] 
Seasonal variation in blood pressure. High 
prevalence of HTN in people with dark skin 
Trend of hypertension in people 18-74 y in US during  1976 to 1980 Drizd and Engel [24] 
(epidemiologic) 
Vitamin D status is lower in blacks compare 
with whites. Blood pressure is higher in blacks 
migrate from north Africa to higher latitude 
compare with people stay in north Africa. 
Study of vitamin D status and HTN in people of north Africa 
compare with blacks migrate to higher latitude s and compare them 
with whites 
M, Buyamba [26] 
(epidemiologic) 
From north to south and near the equatorial, 
prevalence of HTN decreased. 
Participants in national STROKE study in 1985 in 29 provinces in 
China 
He et al. [22] 
(epidemiologic) 
HTN is significantly associated with latitude. More than 10 thousand INTERSALT study[ 21] 
(epidemiologic) 
Intake of calcium and vitamin D was associated 
with decrease in HTN. 
Association of HTN with calcium  and vitamin D intake in 308 
women in different ages 
Sower et al.[ 30] (cross-
sectional) 
Vitamin D stasus was inversely associated with 
HTN 
measurement of vitamin D status in 34 middle age men and the 
association of it with HTN and cardiac risk factors 
Lind et al. [31] (cross-
sectional) 
Systolic and diastolic blood pressure was higher 
in men with lower level of vitamin D. 
Vitamin D measurement  and blood pressure in 100 men aging 
between 25-64 y 
kristal et al. [32] (cross-
sectional) 
Vitamin D status was lower in cold season. It 
was also lower in blacks compare to whites. 
51 black women and 39 white women between 20-40 y in Boston Harris and Huges [25] 
(cross-sectional) 
There was no association between vitamin D and 
decrease in HTN. 
participants from several cohort studies;77436 from Nurse̓ s health 
Study(NHS1), 93803 from NHS2 and 38074 from Health 
professional Follow up Study(HPFS),vitamin D status was detected 
through quintiles according to questionnaires 
Forman et al. [39] (cohort) 
Prevalence of HTN was lower in participants 
with higher levels of vitamin D. 
Estimation of vitamin D status in participants from 2 cohort studies 
NHS and HPFS via questionnaires 
Forman et al. [36] (cohort) 
Prevalence of HTN was lower in participants 
with higher levels of vitamin D. 
Detection of vitamin D status in 613 men from HPFS and 1198 
women from NHS 
Forman et al. [36] (cohort) 
Vitamin D status was associated with HTN. 7186 men and 7902 women in the range of 20 years old and more, 
from Third National Health and Nutrition Examination Survey were 
chosen and vitamin D status was measured. 
Martin et al. [38] (cohort) 
Vitamin D deficiency could be associated with 
HTN and other cardiovascular disease. 
1739 participants from Framingham Offspring Study (white race), 
mean age 59 y, without cardiovascular disease at beginning; vitamin 
D status was measured. About 5.4 y later, the first cardiovascular 
symptoms were emerged. 
Wang et al. [37] (cohort) 
 
Table 3. Interventional studies of the effects of vitamin D on hypertention 
 
Result Design Administration Age Study 
No effect 39 patients with HTN received vitamin DR3 Rfor 8 weeks 
Control group received placebo 
1-α hydroxy vitamin 
DR3R tablet 
middle 
age 
Lind et al. 
[43] 
Supplements did not have 
significant effect on HTN. Vitamin 
D status was high after 
supplementation 
58 middle aged were divided randomly in to 4 groups; 
a-800 mg calcium + DR3  Ras placebo 
b-5µg vitamin DR3R + calcium as placebo 
c-800 mg calcium + 5 µg DR3 
d-both as placebo 
cholecalciferol 
tablet 
50-70y Pan et al.[44] 
Blood pressure changes were equal 
in both groups. Vitamin d status 
was high after supplementation. 
95 men and women received 2.5 mg cholecalciferol 
94 person in control group received placebo 
cholecalciferol 
tablet 
63-76 y Scragg et al. 
[45] 
Decrease in BP about 6.6 mm Hg 
Increase in vitamin D status about 
162% 
3 times a week for 3 months in 18 patients with HTN UVB irradiation 
with Helarium lamp 
26-66 y Krause et al. 
[41] 
BP decreased in group with vitamin 
D supplementation 
calcium supplementation compare with calcium plus 
cholecalciferol tablet tablet for 8 weeks 
cholecalciferol 
tablet 
more 
than 70 y 
Pfeifer et al. 
[42] 
Significant decrease in systolic BP 
in group supplemented with vitamin 
D 
100 patients with HTN received only anti-hypertensive 
drugs; 100 patients received 33000IU vitamin D each 2 
weeks additionally 
cholecalciferol 
tablet 
more 
than 35y 
Goal and 
Harbans [40] 
 
It was observed that the relative risk (6.13) was higher 
among those with lower vitamin D levels. With respect to 
women, the same result was yielded, and the relative risk 
in the group with serum vitamin D levels less than 15 
ng/ml was 2.67. Then, the pooled relative risk, for male 
and female groups, was measured (3.18) using random-
effects model. Forman et al. investigated the relationship 
between the estimated 25-hydroxyvitamin D level and 
blood pressure to strengthen the research capacity and 
achieve more accurate results. By doing this, they were 
able to study this relationship among all participants in 
these two large cohort studies consisting of 38388 men 
and 77531 women. They estimated the 25-
hydroxyvitamin D levels of the participants based on the 
information obtained from them using Food Frequency 
Questionnaire (FFQ). Decile rating was undertaken based 
on serum 25-hydroxyvitamin D level for the participants. 
It was observed that by moving from the first decile 
(lower level of serum vitamin D) to the next deciles 
(higher levels of serum vitamin D) the risk of 
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hypertension decreased. That is, the relative risk in the 
women of the first decile was 2.31 compared with the last 
decile. This figure was 1.57 in men. It is worth 
mentioning that the correlation coefficients between the 
estimated 25-hydroxyvitamin D and measured 25-
hydroxyvitamin D in HPFS and NHS were 0.54 and 0.15, 
respectively [36]. Therefore, a significant inverse 
correlation was detected in this study between serum 
vitamin D level and hypertension in a wide range of 
participants. In another study by Wang et al. 1739 
participants with the average age of 59 years were 
selected from Framingham Offspring. Of them, 55% were 
women and the rest were men. By race, all subjects were 
white with no history of cardiovascular diseases. Their 
levels of 25-hydroxyvitamin D were measured. To adjust 
other hazard and risk factors, the Cox regression was 
employed. In general, in this group, vitamin D levels in 
28% of the subjects were less than 25 ng/ml. During 4.5 
years of follow-up, 120 subjects developed, at least, one 
cardiovascular symptom. Hazard ratio in those with serum 
vitamin D levels less than 15 ng/ml was 1.63 compared 
with those with serum vitamin D levels greater than or 
equal to 15ng/ml. This ratio (2.13) was bigger in the 
subjects with hypertension [37]. Therefore, it was 
determined that vitamin D deficiency could be associated 
with cardiovascular diseases, especially in those with 
hypertension. In another study by Martins et al. on adult 
Americans, they maintained a relationship between the 
serum vitamin D level and the incidence of hypertension. 
The subjects, all from Third National Health and 
Nutrition Examination Survey, included 7186 men and 
7902 women, aged 20 or above. The level of 25-
hydroxyvitamin D was measured and average of about 30 
ng/ml (or 75 nmol/l) was obtained. Quartile rating was 
undertaken for the subjects in an ascending order, based 
on serum 25-hydroxyvitamin D. The subjects in the first 
quartile (1.30) were more prone to hypertension the fourth 
quartile [38]. In another study, in order to investigate the 
relationship between serum vitamin D level and blood 
pressure, a number of separate cohort studies were used. 
These studies included the Nurse’s Health Study (NHS1) 
with 77436 participants, Nurse’s Health Study (NHS2) 
with 93803 participants, and also Health Professional 
Follow-Up Study (HPFS) with 38074 participants. All 
cohorts were followed up for more than 8 years, during 
which the subjects received vitamin D supplement. 
Quintile ranking was undertaken for the subjects based on 
serum vitamin D level. Then, the relative risk of 
hypertension was determined. In contrast to other studies, 
the result indicated that the use of vitamin D had no 
correlation with reduction of blood pressure. 
Multifactorial relative risk for hypertension was, in turn, 
as following for each study: 0.98, 1.13, and 1.03. It is 
worth mentioning that the daily degrees of receiving 
vitamin D supplement in the first and last quintiles were 
less than 400 IU and higher than 1600 IU [39].  
4. Interventional Studies: There are not a lot of studies 
on examining the association between vitamin D intake 
and changes in blood pressure. Goel and Harbans in a 
study compared a group of 100 hypertensive patients who 
were given antihypertensive drugs with another group of 
100 hypertensive patients who, in addition to hypertensive 
drugs, were supplemented with vitamin D (33000 IU, 
after every 2 weeks, for 3 months). Vitamin D 
supplementation group showed a significant decrease in 
systolic blood pressure, this group also showed an 
increase in calcium level with a decrease in serum 
phosphorus. Results of this study confirmed that vitamin 
D supplementation has a role in reducing blood pressure 
in hypertensive patients. Researchers of the study noted 
that vitamin D supplementation could be effective along 
with hypertensive drugs [40].  
In an interesting study, Krause et al. tested UVB 
irradiation for 3 times a week and observed a 162% 
increase in 25-hydroxyvitamin D level. They also 
concluded that the 24-hour mean blood pressure will 
decrease by an average of 6.6 mm Hg [41]. In a double-
blind study on investigating the effect of vitamin D on 
blood pressure, Pfeifer et al. examined the effects of 8 
weeks of supplementation with calcium versus calcium 
plus 800 IU vitamin D3 on blood pressure. The group 
under study consisted of 145 women above 70. They 
found that in women with stage 1 hypertension, calcium 
plus vitamin D supplementation leads to a greater blood 
pressure reduction than calcium alone. In this case, the 
subjects in the calcium group showed a decrease in 
systolic blood pressure of 5.7 mm Hg and diastolic blood 
pressure of 6.9 mm Hg. While compared to vitamin D3 
and calcium group, a decrease in systolic blood pressure 
of 13.1 mm Hg and diastolic blood pressure of 7.2 mm 
Hg was observed. Also, in patients who received 
supplementation, serum 25-hydroxyvitamin D reached 
64.8 nmol/l from 25.6 nmol/l [42]. In another study on 39 
patients with stage 1 diastolic hypertension, one group 
received 1 alpha-hydroxy-vitamin D3 in the form of a 
tablet, while the control group, received placebo. No 
changes were observed in their blood pressure. However, 
these patients did not necessarily suffered from vitamin D 
deficiency [43].Of course, all the interventional studies do 
not share the same view towards the effectiveness of 
vitamin D in reducing blood pressure. For instance, in a 
double-blind intervention study by Pan et al., 58 residents 
of an elderly nursing home were selected. They were, 
then, randomly divided into 4 groups. The first group 
received 800 mg calcium per day, along with vitamin D3, 
as placebo. The second group was given 5µg vitamin D3 
per day. This group also received placebo instead of 
calcium. The third group was given calcium and vitamin 
D3 and the fourth group only received placebo. In all 
groups, calcium level and 25-hydroxyvitamin D were 
directly correlated with supplementation. The mean 
systolic blood pressure showed a slight decrease in the 
group who received only calcium supplement. However, 
it was interesting that the mean systolic pressure in the 
group who received calcium plus vitamin D supplement 
increased. The results were reported as following: calcium 
supplements of 800 mg per day or 5 micrograms of 
vitamin D daily did not have a significant effect on blood 
pressure after 11 weeks [44]. In another study in England, 
Scragg et al. provided 95 men and women (mean age 
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above 70 years) 2.5 mg cholecalciferol, while another 
group of 94 aged-matched subjects received the same 
amount of placebo. A five weeks follow-up was pursued 
in this experiment. The results indicated that 25-
hydroxyvitamin D level in the group with 
supplementation was higher than the other one, while 
changes in blood pressure were similar in both groups, 
without a significant difference. The researchers 
concluded that the increased blood pressure in cold 
seasons is not due to serum vitamin D level reduction 
[45]. 
Studies of Genetic Analysis of Vitamin D Receptor: 
Delmic et al. showed that the polymorphism in Taq1 
region of vitamin D receptor-related gene and the 
differences in this region among the people can be a 
suitable marker to determine how susceptible a person is 
to diseases such as diabetes type II and hypertension [46]. 
In a study in Turkey, Vural and Matlas used RT-qPCR 
technique to investigate polymorphism in vitamin D 
receptor gene in 100 patients with either hypertension or 
diabetes type II versus 100 healthy people.  
The aim of the study was to find out whether regional 
changes in this gene could imply to the disease. The 
results showed that distribution of TT, Tt, and tt 
genotypes among the patients was, in turn, 51%, 46%, 
and 3%. These figures were, in turn, 35%, 49%, and 16% 
among the healthy subjects. The frequency of T allele was 
significantly higher in the control group. According the 
obtained results, the use of RT-qPCR is helpful in 
determination of genotypes and detecting the persons 
susceptible to hypertension or diabetes type II [47]. In 
addition, another study on polymorphism in Fok1 region 
of vitamin D receptor gene was performed using PCR-
RFLP technique. A number of 280 patients with 
hypertension were selected and compared with 200 
subjects having normal blood pressure. The genotypic 
distribution of allele F was significantly higher in the 
patient group. To conclude, the presence of 
polymorphism in the FOK1 region of the vitamin D 
receptor gene is a good marker for detecting hypertension 
susceptible people [48]. 
 
Discussion 
 
Epidemiological studies, in general, point out that 
vitamin D deficiency may correlate with hypertension, 
especially when 25-hydroxyvitamin D level is less than 
15 ng/ml. Apparently, systolic blood pressure is highly 
associated with vitamin D level. 
 It seems that the greater prevalence of vitamin D 
deficiency in northern latitudes and regions far from the 
equator correlates with the prevalence of hypertension in 
these regions. We also know that blood pressure has a 
seasonal variation and is higher in cold seasons, just like 
vitamin D deficiency which occurs more in cold seasons 
of the year when there is pale sunlight. These evidences 
put emphasis on this hypothesis that vitamin D deficiency 
is correlated with hypertension. In a series of cohort and 
interventional studies a relationship was seen between 
serum vitamin D and blood pressure levels, while in some 
other no correlation was observed. The existence of 
polymorphism in vitamin D receptor gene can be a reason 
for these contradictory results, maintaining all people do 
not reflect the same response to vitamin D. Therefore, it is 
recommended that genetic variation, including differences 
in vitamin D receptor related genetic regions, to be 
included in future studies. Among interventional studies, 
there are a studies supporting the idea that vitamin D 
supplementation reduces blood pressure.  
In contrast, there are studies claiming that vitamin D is 
not correlated with blood pressure. It seems that 
difference in dose and duration of vitamin D 
supplementation are the reason for this contradiction; it is 
worth mentioning that in order for vitamin D to affect 
blood pressure, 25-hydroxyvitamin D level should be 
greater than 30 ng/ml (75 nmol/L) which would not be 
obtained by previous recommendations on the use of 200 
IU and 600 IU of vitamin D daily usage for young and 
elderly people respectively. [9]. 
 For this reason, doses of 1000 to 2000 IU per day are 
recommended. It has been stated that even short-term use 
of 4000 IU per day as the loading dose not only is useful, 
but also can elevate the 25-hydroxyvitamin D level to 
more than 30 µg/m; in a shorter time [20]. Inadequate 
duration and dose of vitamin D supplementation can be 
the reason for non-effectiveness of this vitamin on blood 
pressure. Therefore, it is necessary for future studies to be 
conducted on a larger population using appropriate dose 
and enough duration of vitamin D usage to achieve more 
reliable result with respect to the effectiveness of vitamin 
D. In studies that a correlation between vitamin D3 and 
hypertension has been observed, it should be clearly 
determined whether this relationship is directly due to the 
effect of vitamin D on blood pressure or due to its effects 
on anthropometric factors (e.g. weight and fat mass) or on 
the inflammatory markers, indirectly leading blood 
pressure reduction. Therefore, for the purpose of future 
studies, it is better to moderate the interfering factors first, 
and then investigate and report the results.  
Finally, when it is difficult to express a relationship 
between a specific nutritious factor as a cause and a 
chronic disease as the consequence, due to the varieties of 
interfering factors in diet, it is better to study this 
relationship in a more general area. In other words, the 
relationship between regular dietary habits of individuals 
and the chronic disease should become apparent first. 
Obviously, demonstration of such relationship in this way 
would be more precise, scientific, and of course costly. 
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